Alterations in the structure of the epiretinal membranes in PVR - Assumptions and reality;Ultrastrukturelle veränderungen in der struktur epiretinaler membranen bei PVR - Anspruch und wirklichkeit

Klinische Monatsblatter fur Augenheilkunde

Volumn 222, Issue 7, 2005, Pages 568-571

  Vidinova, Christina ^a,c   Voinov, L ^a   Vidinov, N ^b  

^a MILITARY MEDICAL ACADEMY   (Bulgaria)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^c NONE   (United Kingdom)

Author keywords

Electron microscopy; Epiretinal membranes; OCT; PVR; Retinal detachment; Vitrectomy

Indexed keywords

ARTICLE; DISEASE COURSE; EPIRETINAL MEMBRANE; FIBROBLAST; GLIA CELL; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PIGMENT CELL; PIGMENT EPITHELIUM; RETINA PIGMENT DEGENERATION; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; VITREORETINOPATHY;

CELL DEATH; EPIRETINAL MEMBRANE; EXTRACELLULAR MATRIX; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; PIGMENT EPITHELIUM OF EYE; POSTOPERATIVE COMPLICATIONS; PROTEOGLYCANS; RETINAL DEGENERATION; RETINAL DETACHMENT; TREATMENT FAILURE; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE;

EID: 23844494099     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858433     Document Type: Article

References (35)

1. Akira A et al. Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor. Br J Ophthalmol 2000; 84: 1306-1311
2. Anderson D et al. The onset of pigment epithelial proliferation after retinal detachment. Invest Opthalmol Vis Sci 1981; 21: 10-16
3. Asaria Y, Kon C, Bunce C. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy. Ophthalmology 2001; 108: 1179-1183
4. Araiz J, Refojo M, Arroyo M. Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1993; 34: 522-530
5. Bellhorn M et al. Ultrastructure and clinicopathologic correlation of idiopathic preretinal macular fibrosis. Am J Ophtalmol 1975; 79: 366-373
6. Campochiaro P, Jerdan J, Glasser B. The extracellular matrix of human retinal pigment epithelial cells in vivo and its synthesis in vitro. Invest Ophthalmol Vis Sci 1986; 27: 1615-1621
7. Campochiaro P et al. The retinal pigmented epithelium and retinal wound repair. Great Basin Visual Science Symposium 1996; 2: 28-34
8. Casaroli-Marano P, Pagan R, Vilaro S. Epiretinal mesenchimal transition in proliferative vitreoretinopathy: Intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1999; 40: 2062-2072
9. Chandler D et al. The effect of triamcinolone acetonide on a defined experimental model of proliferative vitreoretinopathy. Am J Ophthalmol 1985; 99: 686-690
10. Chapman C, Inverson D. The effect of low molecular weight heparin on proliferative vitreoretinopathy induced in the rabbit eye. Invest Ophthalmol Vis Sci 1992; 33 (Suppl 1): 818-820
11. Charteris D. Proliferative vitreoretinopathy: pathology, surgical management, and adjunctive treatment. British J Ophthalm 1995; 79: 953-960
12. Chee H, Nicolas L, Peng T. Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study. Invest Opthalmol Vis Sci 1999; 40: 705-733
13. Clarkson J, Green W, Massof D. A histopathological review of 168 cases of preretinal membrane. Am J Ophthalmol 1992; 3: 357-365
14. Cowley M, Conway B, Campochiaro P. Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmology 1983; 90: 121-125
15. Committee TRUST. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983; 90: 121-125
16. Fisher S, Erickson P, Lewis G et al. Intraretinal proliferation induced by retinal detachment. Invest Ophthalmol Vis Sci 1991; 32: 1739-1748
17. Foos R et al. Vitreoretinal Juncture - simple epiretinal membranes. Albrecht von Graefes Arch Klin Ophthalmol 1974; 189: 231-250
18. Garthner J. Natural history of fibrocellular epiretinal membranes: a quantitative, autoradiographic, and immunohistichemical study. Br J Ophthalmol 1981; 69: 810-823
19. Gidry C et al. Collagen gel contraction by cells associated with proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1992; 33: 2429-2435
20. Glaser B, Cardin A, Biscoe B. Proliferative vitreoretinopathy: the mechanism of development of vitreoretinal traction. Ophthalmology 1987; 94: 327-332
21. Hariot W, Machemer R. Pigment epithelial repair. Graefes Arch Clin Exp Ophthalmol 1992; 230: 91-100
22. Hiscott P, Grierson I, Mc Leod D. Retinal pigment epithelial cells in epiretinal membranes: An immunohistochemical study. Br J Ophthalmol 1984; 68: 695-698
23. Jerdan J, Pepose J, Michels R. Proliferative vitreoretinopathy membranes: An immunochistochemical study. Ophthalmology 1989; 96 (14): 801-810
24. Kon C, Occleston N. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest Ophthalmol Vis Sci 1999; 40: 705-712
25. Machemer R, Laqua H. A logical approach to the treatment of massive preretinal proliferation. Ophthalmology 1978; 85: 584-593
26. Pauleikhoff D, van Kuijk F, Bird A. Makuläres Pigment und AMD. Ophthalmologe 2001; 98: 511-519
27. Rachel W, Burton T. Changing concepts of failures after retinal detachment surgery. Arch Ophthalmol 1979; 97: 480-483
28. Rachel W, Burton T. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983; 90: 121-125
29. Sebestyen J et al. Fibrinoid syndrome: A severe complication of vitrectomy surgery in diabetics. Ann Ophthalmol 1982; 14: 853-856
30. Vinores S et al. Ultrastructural and immunocytochemical changes in retinal pigment epithelium, retinal glia and fibroblasts in vitreous culture. Invest Ophthalmol Vis Sci 1990; 31: 2529-2545
31. Vinores S et al. A morphological and immunohistochemical study of human retinal pigment epithelial cells, retinal glia and fibroblasts grown on Gelform matrix in an organ culture system. Graefes Arch Clin Exp Ophthalmol 1993; 231: 279-288
32. Weler M, Wiedemann P. Proliferative vitreoretinopathy - is it anything more than wound healing at the wrong place? Int Ophthalmol 1990; 14: 105-117
33. Wiedemann P, Hilgers R. Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 1991; 229: 150-152
34. Wiedemann P, Lemmen K. Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy. Am J Ophthalmol 1987; 104: 10-14
35. Yang C, Khawly J, Chen S. An intravitreal sustained release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy. Arch Ophthalmol 1998; 116: 69-77